NM_001167.4:c.688G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001167.4(XIAP):​c.688G>A​(p.Val230Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000479 in 1,210,373 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., 11 hem., cov: 23)
Exomes 𝑓: 0.000021 ( 0 hom. 2 hem. )

Consequence

XIAP
NM_001167.4 missense

Scores

4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 5.23

Publications

0 publications found
Variant links:
Genes affected
XIAP (HGNC:592): (X-linked inhibitor of apoptosis) This gene encodes a protein that belongs to a family of apoptotic suppressor proteins. Members of this family share a conserved motif termed, baculovirus IAP repeat, which is necessary for their anti-apoptotic function. This protein functions through binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 and inhibits apoptosis induced by menadione, a potent inducer of free radicals, and interleukin 1-beta converting enzyme. This protein also inhibits at least two members of the caspase family of cell-death proteases, caspase-3 and caspase-7. Mutations in this gene are the cause of X-linked lymphoproliferative syndrome. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 2 and 11.[provided by RefSeq, Feb 2011]
XIAP Gene-Disease associations (from GenCC):
  • X-linked lymphoproliferative disease due to XIAP deficiency
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06323764).
BP6
Variant X-123886350-G-A is Benign according to our data. Variant chrX-123886350-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 533658.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000312 (35/112120) while in subpopulation AFR AF = 0.00113 (35/30845). AF 95% confidence interval is 0.000838. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XIAPNM_001167.4 linkc.688G>A p.Val230Ile missense_variant Exon 2 of 7 ENST00000371199.8 NP_001158.2 P98170

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XIAPENST00000371199.8 linkc.688G>A p.Val230Ile missense_variant Exon 2 of 7 1 NM_001167.4 ENSP00000360242.3 P98170

Frequencies

GnomAD3 genomes
AF:
0.000312
AC:
35
AN:
112120
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000654
AC:
12
AN:
183492
AF XY:
0.0000294
show subpopulations
Gnomad AFR exome
AF:
0.000836
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000122
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000209
AC:
23
AN:
1098253
Hom.:
0
Cov.:
32
AF XY:
0.00000550
AC XY:
2
AN XY:
363609
show subpopulations
African (AFR)
AF:
0.000606
AC:
16
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54149
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40526
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000831
AC:
7
AN:
842142
Other (OTH)
AF:
0.00
AC:
0
AN:
46098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000312
AC:
35
AN:
112120
Hom.:
0
Cov.:
23
AF XY:
0.000321
AC XY:
11
AN XY:
34276
show subpopulations
African (AFR)
AF:
0.00113
AC:
35
AN:
30845
American (AMR)
AF:
0.00
AC:
0
AN:
10460
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3603
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2727
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6113
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53285
Other (OTH)
AF:
0.00
AC:
0
AN:
1516
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000112
Hom.:
6
Bravo
AF:
0.000348
ESP6500AA
AF:
0.00156
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000824
AC:
10

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Apr 10, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.688G>A (p.V230I) alteration is located in exon 2 (coding exon 1) of the XIAP gene. This alteration results from a G to A substitution at nucleotide position 688, causing the valine (V) at amino acid position 230 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

X-linked lymphoproliferative disease due to XIAP deficiency Benign:1
Nov 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.068
T;T;T
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.84
T;.;.
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.063
T;T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
1.2
L;L;L
PhyloP100
5.2
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.020
N;N;N
REVEL
Benign
0.20
Sift
Benign
0.11
T;T;T
Sift4G
Benign
0.45
T;T;T
Polyphen
0.24
B;B;B
Vest4
0.16
MVP
0.29
MPC
0.34
ClinPred
0.12
T
GERP RS
5.8
Varity_R
0.32
gMVP
0.41
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144884904; hg19: chrX-123020200; API